The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
The effect of VEGF on T cells from ovarian cancer patients and healthy individuals via VEGF receptor type 2.
F. Zagouri
No relevant relationships to disclose
A. Ziogas
No relevant relationships to disclose
N. Gavalas
No relevant relationships to disclose
M. Tsiatas
No relevant relationships to disclose
O. Tsitsilonis
No relevant relationships to disclose
E. Politi
No relevant relationships to disclose
C. Liakou
No relevant relationships to disclose
A. Karadimou
No relevant relationships to disclose
K. Arapini
No relevant relationships to disclose
E. Terpos
No relevant relationships to disclose
M. A. Dimopoulos
No relevant relationships to disclose
A. Bamias
No relevant relationships to disclose